Janney Capital initiated coverage on Tonix Pharmaceuticals Holding Corp. TNXP with a Buy rating.
The target price for Tonix Pharmaceuticals is set to $10.
Tonix Pharmaceuticals shares have dropped 29.58 percent over the past 52 weeks, while the S&P 500 index has surged 10.90 percent in the same period.
Tonix Pharmaceuticals' shares fell 0.50 percent to close at $6.00 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in